We are live on !
Find out more
StepStone Group Portfolio holdings
AUM
$2.16B
Turnover
48.15%
1-Year Est. Return
20.11%
This Fund
S&P 500
This Quarter Est. Return
-2.15%
1 Year Est. Return
-20.11%
3 Year Est. Return
+103.33%
5 Year Est. Return
+4.43%
10 Year Est. Return
+216.71%
AUM
$71.9M
AUM Growth
+$33.6M
(+88%)
Cap. Flow
+$29.9M
Cap. Flow % of AUM
Cap. Flow %
41.67%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
–
Closed
1
Avg Time Held
1.8
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NovoCure
NVCR
|
+$26.1M |
| 2 |
Veeva Systems
VEEV
|
+$3.92M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.17% |
| 2 | Consumer Discretionary | 29.93% |
| 3 | Financials | 5.61% |
| 4 | Communication Services | 1.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
NovoCure
NVCR
$1.82B
| $26.3M | 36.57% |
+1,815,479
| New | +$26.1M |
2016 Q1
0 quarters
|
|
2
DELISTED
Asensus Surgical, Inc.
ASXC
| $14.8M | 20.58% |
267,732
| – | – |
2014 Q2
7 quarters
|
|
3
DELISTED
Caesars Entertainment Corporation
CZR
| $11.3M | 15.75% |
1,665,032
| – | – |
2013 Q2
11 quarters
|
|
|
CACQ
4
DELISTED
Caesars Acquisition Company
CACQ
| $10.2M | 14.18% |
1,665,032
| – | – |
2014 Q1
8 quarters
|
|
5
Fidus Investment
FDUS
$727M
| $4.03M | 5.61% |
260,105
| – | – |
2013 Q2
11 quarters
|
|
|
6
Veeva Systems
VEEV
$51.9B
| $4.01M | 5.57% |
+160,000
| New | +$3.92M |
2016 Q1
0 quarters
|
|
7
QuinStreet
QNST
$938M
| $924K | 1.29% |
270,114
| – | – |
2013 Q4
9 quarters
|
|
8
Alphatec Holdings
ATEC
$1.68B
| $323K | 0.45% |
112,015
| – | – |
2013 Q3
10 quarters
|
|
Similar funds
NM
StepStone Group's Q1 2016 Portfolio in Review
As of Q1 2016, StepStone Group held 9 positions worth $71.9M, up 88% from $38.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
StepStone Group deployed $29.9M of net new capital in Q1 2016, opening 2 new positions. Its largest new stake was NovoCure: 1,815,479 shares worth $26.3M.
By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- StepStone Group's largest Q1 2016 buy was NovoCure: 1,815,479 shares worth $26.3M.
- StepStone Group's ten largest holdings make up 100% of its $71.9M portfolio in Q1 2016.
- StepStone Group opened 2 new positions and closed 1 in Q1 2016.
- StepStone Group's portfolio value rose 88% quarter-over-quarter to $71.9M.
Based on StepStone Group's 13F filing for Q1 2016, filed 13 May 2016.